Re-irradiation for pelvic and groin cancer recurrences
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests giving radiation again to treat a cancer that has returned in the pelvic area (including the groin) when surgery isn’t a good option. It may help control the tumor while trying to protect nearby organs such as the small intestine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be able to do daily activities at least at a moderate level (Karnofsky score 70 or higher)
- Have a confirmed pelvic and groin recurrence on scan or tissue test
- Have had previous radiation to the pelvis, and there is no spread to distant organs or the disease has been stable for at least 6 months
- Have the tumor at least 10 mm away from the small intestine on imaging, or be able to have intestinal loops moved and a spacer placed if needed
- Have a way to get clear imaging for planning (MRI able to be assessed, and no metal/hip prosthesis that blocks targeting)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether carbon ion radiation can control mucosal melanoma in the lower female genital tract. It may help by targeting the tumor with high-precision radiation while trying to protect nearby organs like the bladder and rectum.
This trial studies a targeted, high-intensity radiation approach given after prostate removal surgery when prostate cancer seems to be coming back locally. It may help control the disease in the pelvis while avoiding treatment that could cause more side effects.
This trial studies using additional radiation or tumor-destroying techniques for gynecologic cancer that has come back after previous radiation treatment. It helps doctors understand if this approach is safe and effective for women with recurrent disease.
This study looks at combining total neoadjuvant therapy (chemotherapy and radiation) for rectal cancer that has come back in the pelvis after earlier radiation. It aims to see if this treatment approach can help control the disease and improve outcomes in patients with limited spread that can potentially be removed or treated.
This study looks at giving radiation and/or chemotherapy before surgery for rectal cancer that has come back in the pelvis. The goal is to see if this approach can shrink the tumor and make it easier to remove, potentially improving outcomes.
This study tests a new way to plan a second course of radiation for cancer that has returned or spread to a few places. It uses special imaging software to make the treatment more precise and aims to improve outcomes.
Hear when a new Tumor Recurrence trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.